Education
About Us
Working with TipRanks
Follow Us
Telesis Bio (TBIO)
OTHER OTC:TBIO
Total Valuation
Telesis Bio has a market cap or net worth of $20.42K. The enterprise value is ―.
Market Cap$20.42K
Enterprise Value―
Share Statistics
Telesis Bio has 1,775,839 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,775,839
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Telesis Bio’s return on equity (ROE) is -1.62 and return on invested capital (ROIC) is -72.70%.
Return on Equity (ROE)-1.62
Return on Assets (ROA)-0.68
Return on Invested Capital (ROIC)-72.70%
Return on Capital Employed (ROCE)-0.75
Revenue Per Employee705.36K
Profits Per Employee-1.22M
Employee Count39
Asset Turnover0.39
Inventory Turnover2.62
Valuation Ratios
The current PE Ratio of Telesis Bio is -4.49. Telesis Bio’s PEG ratio is <0.01.
PE Ratio-4.49
PS Ratio0.00
PB Ratio0.13
Price to Fair Value7.26
Price to FCF-0.02
Price to Operating Cash Flow-0.02
PEG Ratio<0.01
Income Statement
In the last 12 months, Telesis Bio had revenue of 27.51M and earned -47.72M in profits. Earnings per share was -1.64.
Revenue27.51M
Gross Profit16.95M
Operating Income-46.54M
Pretax Income-47.70M
Net Income-47.72M
EBITDA-40.49M
Earnings Per Share (EPS)-1.64
Cash Flow
In the last 12 months, operating cash flow was -22.85M and capital expenditures -890.00K, giving a free cash flow of -23.74M billion.
Operating Cash Flow-22.85M
Free Cash Flow-23.74M
Free Cash Flow per Share-13.37
Dividends & Yields
Telesis Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.16
52-Week Price Change-94.59%
50-Day Moving Average0.40
200-Day Moving Average1.17
Relative Strength Index (RSI)48.86
Average Volume (3m)5.29K
Important Dates
Telesis Bio upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
Telesis Bio as a current ratio of 3.71, with Debt / Equity ratio of 420.52%
Current Ratio3.71
Quick Ratio3.22
Debt to Market Cap0.02
Net Debt to EBITDA-0.81
Interest Coverage Ratio-14.99
Taxes
In the past 12 months, Telesis Bio has paid 24.00K in taxes.
Income Tax24.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Telesis Bio EV to EBITDA ratio is -6.10, with an EV/FCF ratio of -6.74.
EV to Sales8.98
EV to EBITDA-6.10
EV to Free Cash Flow-6.74
EV to Operating Cash Flow-7.13
Balance Sheet
Telesis Bio has $4.51M in cash and marketable securities with $16.29M in debt, giving a net cash position of $11.78M billion.
Cash & Marketable Securities$4.51M
Total Debt$16.29M
Net Cash$11.78M
Net Cash Per Share$6.63
Tangible Book Value Per Share$0.83
Margins
Gross margin is 33.82%, with operating margin of -169.18%, and net profit margin of -173.49%.
Gross Margin33.82%
Operating Margin-169.18%
Pretax Margin-173.40%
Net Profit Margin-173.49%
EBITDA Margin-147.20%
EBIT Margin-162.11%
Analyst Forecast
The average price target for Telesis Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-54.89%
EPS Growth Forecast-19.78%